Introduction
Th e pregnancy outcomes low birth weight (2500 g) and small for gestational age (SGA; 10th percentile of reference population) that are due to intrauterine growth restriction are major determinants of children's future health and development. At the short term, infants born with low birth weight or SGA are at increased risk of infant mortality and morbidity, 1 while at the long term, they have higher risks of metabolic and cardiovascular diseases. 2, 3 Although adequate maternal nutrition has since long been accepted as vital to fetal growth, it is still largely unclear to what extent which (combinations of) nutrients matter. 4, 5 Consequently, no evidence-based nutritional preventive strategies exist at this stage. Among the nutrients with potential clinical relevance, the essential fatty acids α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6) , and more particular their longer-chain, more-unsaturated derivatives (commonly referred to as long-chain polyunsaturated fatty acids, LC-PUFAs) have increasingly gained interest. LC-PUFAs are key components of virtually all cellular membranes and, besides, exert a wide array of biological functions. 6, 7 Although LC-PUFAs are considered essential for fetal growth, evidence of their growth-promoting eff ect is limited.
Results of the few small-sized observational studies that directly measured n-3 and n-6 fatty acid concentrations, either maternal, 8 neonatal, 9 or both, [10] [11] [12] are inconclusive. Evidence from existing randomized clinical trials is restricted to maternal n-3 LC-PUFA intake only; although positive associations are reported, these are commonly interpreted as the consequence of a prolonged gestation rather than a direct eff ect on fetal growth. 13, 14 In the present large cohort study, we explore the potential role of the maternal n-3 and n-6 fatty acid profi le in fetal growth by investigating in detail the association between maternal concentrations of these fatty acids during early pregnancy and infant birth weight at term. We also explore the role of elaidic acid (18:1n-9t), the main industrial trans fatty acid in the diet, which can inhibit the conversion of α-linolenic acid and linoleic acid to their respective LC-PUFAs and was suggested to inhibit fetal growth. 15 Th e simultaneous measurement of a predefi ned set of cofactors relevant to fetal growth enables us to investigate the independent association of these maternal diet-derived fatty acids with infant birth weight. If the early pregnancy fatty acid profi le proves to be relevant, this may open new avenues for optimizing infant development and disease prevention by adaptation of the maternal fatty acid status.
Subjects and methods

Study population and design
Th is study is part of the Amsterdam Born Children and their Development (ABCD) study, a prospective community-based cohort study that examines the relationship between maternal lifestyle and psychosocial conditions during pregnancy and the child's health at birth as well as in later life. Essentials of the study design were described previously. 16 In short, between January 2003 and March 2004, all pregnant women living in Amsterdam were invited to enroll in the ABCD study at their fi rst prenatal visit to the obstetric care provider (around the 12th week of gestation) and were requested to complete a questionnaire, covering sociodemographic data, obstetric history, lifestyle, dietary habits, and psychosocial factors. Th e questionnaire was available in Dutch and in English, Turkish, or Arabic for immigrant women. In addition, women were invited to participate in the ABCD biomarker study. For this, an additional blood sample was taken during routine blood collection for screening purposes aft er the fi rst prenatal checkup.
Of the invited 12 373 pregnant women, 8266 returned the pregnancy questionnaire (response rate 67%). Of those respondents, 53% (n = 4389) participated in the biomarker study. Approval of the study was obtained from the Medical Ethical Committees of participating hospitals and the Registration Committee of Amsterdam. Written informed consent was obtained from all participants.
Measurements
Primary outcome variables for this study were birth weight (in grams) and SGA (yes, no) at term, with SGA defi ned as a birth weight below the 10th percentile for gestational age on the basis of sex-and parity-specifi c standards from the Netherlands Perinatal Registry (data available from the authors upon request). Date of birth, birth weight, infant sex, and gestational age [ultrasound-based or, if unavailable (10%), based on time of last menstrual period], as recorded by the obstetric care providers, were obtained through the Youth Health Department at the Municipal Health Service in Amsterdam. Gestational age at blood sampling was calculated with the available information on gestational age at birth, date of birth, and date of blood sampling. Information on maternal physiologic, lifestyle and sociodemographic characteristics was obtained from the questionnaire.
Th e sociodemographic covariables included cohabitant status (living together with partner, not living together/single), educational attainment aft er primary school (d5, 6-10, t11 y), and ethnicity. Ethnicity was defi ned by country of birth and included the following categories, based on the Dutch main ethnic populations: the Netherlands, Surinam, Turkey, Morocco, other non-Western country, and other Western country.
Lifestyle factors included self-reported alcohol consumption (last week's consumption, recoded into yes, no), self-reported smoking (last week's behavior, recoded into yes, no), pre-gravid body mass index (BMI, in kg/m 2 ) based on self-reported height and weight, and psychosocial stress (presence of 0, 1, or t2 stressors). A random imputation procedure with the use of linear regression analysis was used to complete missing data on height (3.8% missing) or weight (9.9% missing). 17 Psychosocial stressors were measured by validated Dutch versions of internationally accepted questionnaires and included depression, 18 for nonnormal scores were, in absence of internationally agreed cutoff points for pregnant women, chosen at the 90th percentile. Self-reported maternal physiologic characteristics were parity (0, t1), age (d24, 25-34, and t35 y) and height.
Biochemical analyses
For each participant of the biomarker study, one blood sample was taken in a 10-mL EDTA(K2) evacuated tube (Vacutainer; Becton Dickinson BV, Alphen aan de Rijn, Th e Netherlands) and sent to the Regional Laboratory of Amsterdam for processing. Transport was by courier or by overnight mail in special envelopes, enabling processing within 28 h of sampling. A previous study of our group showed that this delay did not compromise the validity of measured biomarkers. 23 At the laboratory, plasma was prepared by centrifugation (1600 x g for 10 min at room temperature) and stored as 1-mL aliquots at −80qC until analysis.
Fatty acid analysis was performed at the Analytical Biochemical Laboratory (ABL, Assen, the Netherlands), as previously described. 24, 25 In short, aft er the addition of an internal standard (1,2-dinonadecanoyl-sn-glycero-3-phosphocholine) and 10-heptadecenoic acid (17:1) to check for carryover of free fatty acids during the isolation procedure, plasma lipid extracts were prepared by a modifi ed Folch extraction method 26 aft er which phospholipids were isolated by solid-phase extraction on aminopropyl-silica columns (500 mg/3 mL, Varian, Palo Alto, CA, USA). 27 Phospholipids were then hydrolyzed and the resulting fatty acids were methylated with boron trifl uoride-methanol. 28 Finally, the fatty acid methyl esters were separated and quantifi ed by capillary gas chromatography with fl ame ionization detection (HP5890 series II, Hewlett Packard, Palo Alto, CA, USA), with the use of a polar and a nonpolar column (BPx70 and BP1, respectively, SGE Analytical Science Pty. Ltd, Ringwood, Victoria, Australia). Th e oven temperature was programmed to begin at 160qC for 4 minutes, and then to increase to 200qC by 6.0 qC/min. Aft er 3 minutes, the temperature was further increased to 260qC at a rate of 7 qC/min and kept constant for 2.34 min. Th e injector temperature was kept at 250qC and the detector temperature at 300qC.
Absolute amounts of fatty acids (in mg/L plasma) were quantifi ed on the basis of recovery from the internal standard and calculated in relative values (percentage of total fatty acids). For the present study, the following fatty acids were relevant and will be presented: the trans fatty acid elaidic acid (18:1n-9t), the essential fatty acids α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6), and their respective LC-PUFAs eicosatetraenoic acid (20:4n-3), eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3), docosahexaenoic acid (DHA, 22:6n-3), dihomo-γ-linolenic acid (DGLA, 20:3n-6), arachidonic acid (AA, 20:4n-6), adrenic acid (22:4n-6) and Osbond acid (22:5n-6). Interassay coeffi cients of variation for these fatty acids varied from d22% (for 20:4n-3, the fatty acid with the lowest concentration) to d2% (for 18:2n-6, the fatty acid with the highest concentration). Th e essential fatty acid derivatives γ-linolenic acid (18:3n-6) and stearidonic acid (18:4n-3) were not included, because their concentrations were 0.1% of total fatty acids. Other measured, nonessential fatty acids were not considered because they were outside the scope of our study. 
Statistical analysis
Fatty acid results were available for 4336 of the 4389 participants. From this group, 4112 women gave birth to a liveborn singleton infant for whom information on birth weight and gestational age was available. We excluded all respondents with known diabetes (n = 21) or hypertension (n = 127) at the time of blood sampling, respondents who delivered preterm (n = 213), and respondents with missing values on t1 of above-mentioned covariables (n = 55). Th e fi nal sample available for analysis was 3704.
Aft er a descriptive analysis of fatty acid concentrations, outcome variables, and maternal and infant characteristics, the univariate (i.e., unadjusted) associations between individual maternal fatty acid concentrations and infant birth weight were explored by linear regression analyses. For each fatty acid, 2 separate models were explored: (1) a continuous model, which included the SD-score as continuous measure of fatty acid concentrations, and (2) a categorical model, which included quintiles as categorical measure of fatty acid concentrations. Th e categorical model was chosen to explore the potential nonlinearity of the association; with the use of the middle quintile as reference, this analysis allowed us to examine whether associations were apparent over the full exposure distribution or at the extremes only, as observed before for the n-3 LC-PUFAs. 29 Subsequently, multivariate analyses with the use of a stepwise hierarchical approach were performed to assess the adjusted contributions of the individual fatty acids. In the fi rst step (model 1) we included maternal physiologic characteristics (see Measurements), infant sex, gestational age at birth, and gestational age at blood sampling. Th e latter covariate was included to standardize for changes in fatty acid concentration that normally occur during pregnancy. 24 In the second step (model 2) we subsequently added all lifestyle and sociodemographic factors. Finally, to assess the association between the overall maternal fatty acid profi le and birth weight, thereby taking into account their metabolic interrelations, 6, 30 we calculated a cumulative exposure score. For each fatty acid a dichotomous (0,1) classifi cation of exposure was determined on the basis of its univariate association with birth weight. For each fatty acid positively associated with birth weight (i.e., for 6 fatty acids, see Results) the lowest quintile was scored as 1 (exposure); for each fatty acid negatively associated with birth weight (5 fatty acids), the highest quintile was scored as 1. Aft er summation of the scores for each of the 11 fatty acids (the so-called cumulative exposure score), multivariate linear regression analysis was performed to explore the association between this cumulative exposure score and birth weight. To allow for suffi ciently sized groups for comparison, scores were combined into 4 categories: 0-1, 2-3, 4-5, and t6, with the latter category defi ned as the most adverse profi le.
All regression analyses were repeated using logistic regression to explore the associations between maternal fatty acid status and SGA. Associations were considered signifi cant at P 0.05. All analyses were conducted in SPSS version 14.0 (SPSS Inc., Chicago, IL, USA). 
Results
Characteristics of the included mother-infant pairs (n = 3704) are presented in Table 7 .1; maternal fatty acid concentrations with quintile distributions are shown in Table 7 .2. Blood samples were taken at a mean (r SD) gestational duration of 13.5 r 3.3 wk. Compared with the infants born to mothers who did not provide a blood sample (n = 3564; data not shown), the infants included in the present study were more oft en of the female sex, less oft en born SGA and had higher birth weights. Th e included mothers were older, taller, and higher educated; had a lower BMI; experienced less stress; and were more likely to consume alcohol. Th ey were also more oft en nulliparous and of Dutch origin and were less oft en living alone.
Univariate regression results showed that birth weight was positively related to all n-3 fatty acids as well as the n-6 LC-PUFA DGLA (20:3n-6), but negatively related to all other n-6 fatty acids and elaidic acid (18:1n-9t) ( Table 7. Given the nonlinearity of the univariate results, multivariate analyses were restricted to the categorical model. Overall, adjustment did not change directions of the associations. Adjustment for physiologic factors (model 1) however largely attenuated the estimates, whereas additional adjustment for lifestyle and sociodemographic factors (model 2) showed less eff ect. Aft er full adjustment, the n-3 LC-PUFA EPA and the n-6 LC-PUFAs DGLA and AA were still signifi cantly associated with birth weight (estimated diff erence compared with reference: −55 and −57 grams for lowest quintiles of EPA and DGLA, respectively, and −52 grams for the highest quintile of AA).
Results for SGA were largely similar. Th e univariate categorical models demonstrated increased risks of SGA at lower concentrations of most n-3 fatty acids (exception: α-linolenic acid and DHA) and the n-6 fatty acid DGLA, and at higher concentrations of most other n-6 fatty acids (exception: Osbond acid) ( Table 7 .4). Again, adjustment did not change directions of the associations but attenuated the univariate estimates. Aft er full adjustment (model 2), signifi cantly increased risks of delivering an infant that was SGA were still observed for women with the lowest concentrations of n-3 eicosatetraenoic acid [odds ratio (OR): 1.50; 95% CI: 1.07, 2.11] and DPA (OR: 1.49; 95% CI: 1.06, 2.10). For DGLA, the largest increase in risk was observed for women in the 2 lowest quintiles; however, the increase was only signifi cant for women in the second quintile (OR: 1.38; 95% CI: 1.00, 1.91). Th e multivariate exposure score analysis showed that the largest decreases in birth weight and increases in risk of SGA were observed for the ≈20% women with scores t4. Infants born to these mothers were on average 72 g lighter and 1.5 times (95% CI: 1.14, 2.06 times) more likely to be SGA than infants born to mothers with the lowest score. Infants born to the 7% mothers with the most adverse fatty acid profi le (score t6) were 125 g lighter and twice as likely to be SGA (95% CI: 1.44, 3.13) ( Table 7 .5). 
Discussion
Th e results of this large, community-based cohort study suggest that the maternal n-3 and n-6 fatty acid status early in pregnancy aff ects fetal growth. Aft er adjustment for relevant covariables, both low maternal plasma concentrations of n-3 eicosatetraenoic acid, EPA, and DPA, and of the n-6 LC-PUFA DGLA, and high concentrations of the n-6 LC-PUFA AA were associated with reduced fetal growth, with an estimated 50-60-g decrease in birth weight and 40-50% increase in risk of SGA. Th e observed negative association between the maternal elaidic acid concentration, the major dietary trans fatty acid, and fetal growth disappeared aft er adjustment. To overcome potential interpretation problems resulting from metabolic interrelations between n-3, n-6, and trans fatty acids, 6, 30 we developed a measure to defi ne an adverse fatty acid profi le. Results showed, for infants of the 7% mothers with the most adverse profi le, a growth diff erence comparable to the estimated eff ect of smoking, 31 with a 125-g lower birth weight and 100% higher risk of SGA. A lower threshold of adversity, defi ning just over 20% of the women to have an adverse profi le, still corresponded with a 72-g decrease in birth weight and a 50% increase in risk of SGA. Even if we recognize the independent importance of other physiologic factors, these results, if confi rmed, off er perspectives for the dietary prevention of lower birth weight.
Few studies have addressed the association between maternal fatty acid status as measured in blood samples (serum, plasma, or erythrocytes) and birth weight. 8, [10] [11] [12] In none of the studies signifi cant associations were however reported, possibly by lack of power (n for maternal samples d 582). Th e remaining observational evidence on the role of trans, n-6, and n-3 fatty acids in fetal growth rests on studies addressing either maternal intake 29, [32] [33] [34] [35] [36] or neonatal status. [9] [10] [11] [12] 37 Two previous cross-sectional studies investigated the growth-restrictive potential of trans fatty acids in term infants, 12, 37 with inconsistent results. Our results do not suggest a major infl uence of trans fatty acids on fetal growth, but, because trans concentrations in our population were relatively low, 15 we cannot exclude a negative association at higher intakes. Th e single available cross-sectional study investigating n-6 status of term infants in detail 11 agrees with our fi ndings for AA and DGLA. Th e apparent opposite eff ect of DGLA to AA is diffi cult to comprehend, but it may involve maternal insulin activity. DGLA as well as its n-3 counterpart eicosatetraenoic acid are elongation products of γ-linolenic acid and stearidonic acid, respectively, which are formed in the human body by enzymatic conversion of the parent essential fatty acids linoleic acid (for γ-linolenic acid) and α-linolenic acid (for stearidonic acid). Th e enzyme involved, δ-6 desaturase, is stimulated by insulin, 38 a hormone also known to infl uence fetal growth. 39 Alternatively, the AA-DGLA contrast may result from competitive inhibition between AA and DGLA, as suggested for the anti-infl ammatory eff ect of DGLA. 40 Indeed, our eff ect estimates for DGLA resemble those of the n-3 LC-PUFA EPA, a wellestablished AA competitor. In comparison with the larger n-3 intake studies, our n-3 LC-PUFA results are in keeping with those of Olsen and Secher 29 and Rogers et al, 36 who reported an ≈80-g reduction in birth weight aft er adjustment for gestational age, and an (unadjusted) 40-70% increase in intrauterine growth restriction at low n-3 intake.
At this stage, it is diffi cult to relate our fi ndings to existing randomized clinical trials, even if results appear convergent. So far, no trial in a similar low-to-moderate risk population has commenced supplementation before the 15th week of pregnancy, whereas our results particularly support the possibility of an early eff ect. In addition, supplements have been restricted to n-3 fatty acids alone and, fi nally, success or failure may have been infl uenced by the background fatty acid status. 41 Nevertheless, the established eff ect of n-3 LC-PUFA supplementation in late gestation on pregnancy duration, 13, 14 in combination with our results, marks the relevance of fatty acid supplementation as preventive option at all phases of pregnancy.
Some limitations and strengths of our study should be addressed. Despite the large sample size, our results apply to a relatively healthy sample of pregnant women; our estimates may therefore be too conservative. We were able to measure the maternal fatty acid status in early pregnancy but, given the low-intrusive design, not thereaft er. However, our results are not likely to be infl uenced by changes in fatty acid status in late gestation. Longitudinal studies have suggested that early pregnancy profi le well predicts fatty acid profi le later in pregnancy. 24, 42 Moreover, our theoretical point of departure was based on existing evidence that the trajectory of fetal growth and development is set at this early stage. 43 A strength of our study is the nonlinear statistical approach, which clearly showed the insuffi ciency of standard correlational analysis to describe associations. As can be expected from other biological relations, 44 a linear relation between determinant and outcome is an exception rather than rule in a normal population.
Th e implications of low birth weight for longer-term health and development of children are well established, [1] [2] [3] and it has been suggested that, even within the normal range, reduced birth weight may infl uence a child's cognitive development. 45 Our results, though observational and only indicative of causal relations, suggest that dietary adaptation of the maternal fatty acid profi le may help prevent fetal growth restriction, thereby improving later health. Such adaptation may be obtained by supplying additional J-linolenic acid, EPA, or both, which has been shown to raise concentrations of DGLA and EPA, respectively, without increasing AA. 46 Given the consequences of a lower birth weight for the child both at birth and at later age, a study investigating the feasibility and potential benefi ts of such intervention is worthwhile. 
